Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ANVSNASDAQ:PDPNASDAQ:RENENYSEARCA:SBM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANVSAnnovis Bio$12.76+7.4%$10.44$5.42▼$22.49$140.49M1.59268,207 shs489,991 shsPDPInvesco Dorsey Wright Momentum ETF$93.740.0%$95.45$72.68▼$99.60$1.21B1.0226,501 shs30,299 shsRENECartesian Growth Co. II$11.20$11.11$10.52▼$11.92$242.14M-0.0157,465 shs280 shsSBMProShares Short Basic Materials$46.38$46.38$42.85▼$55.15$1.86MN/A3,024 shsN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANVSAnnovis Bio+3.61%+18.93%+5.26%+30.97%-19.62%PDPInvesco Dorsey Wright Momentum ETF+2.03%0.00%-5.15%+8.22%+22.86%RENECartesian Growth Co. II+0.18%+0.27%+0.90%+1.63%+6.46%SBMProShares Short Basic Materials-0.01%0.00%0.00%0.00%-0.01%The #1 Biotech Stock to Have on Your Radar in 2024… (Ad)Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANVSAnnovis Bio1.1776 of 5 stars3.41.00.00.01.31.70.6PDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/AN/AN/AN/ASBMProShares Short Basic MaterialsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANVSAnnovis Bio2.75Moderate Buy$27.75117.48% UpsidePDPInvesco Dorsey Wright Momentum ETF0.00N/A$96.482.92% UpsideRENECartesian Growth Co. IIN/AN/AN/AN/ASBMProShares Short Basic Materials0.00N/AN/AN/ACurrent Analyst RatingsLatest PDP, DEST, RENE, ANVS, and SBM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2024ANVSAnnovis BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.003/21/2024ANVSAnnovis BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.002/28/2024ANVSAnnovis BioBrookline Capital ManagementSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$9.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANVSAnnovis BioN/AN/AN/AN/A($0.73) per shareN/APDPInvesco Dorsey Wright Momentum ETFN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/A$0.40 per share28.09($0.64) per shareN/ASBMProShares Short Basic MaterialsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANVSAnnovis Bio-$56.20M-$6.22N/AN/AN/AN/A-446.06%-257.97%5/9/2024 (Estimated)PDPInvesco Dorsey Wright Momentum ETFN/AN/A25.46∞N/AN/AN/AN/AN/ARENECartesian Growth Co. II$11.44MN/A0.00∞N/AN/A-65.59%5.02%N/ASBMProShares Short Basic MaterialsN/AN/A0.00∞N/AN/AN/AN/AN/ALatest PDP, DEST, RENE, ANVS, and SBM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/29/2024Q4 2023ANVSAnnovis BioN/A-$1.09-$1.09$0.15N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANVSAnnovis BioN/AN/AN/AN/AN/APDPInvesco Dorsey Wright Momentum ETF$0.250.27%N/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/ASBMProShares Short Basic MaterialsN/AN/AN/AN/AN/ALatest PDP, DEST, RENE, ANVS, and SBM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/15/2024PDPInvesco Dorsey Wright Momentum ETFQuarterly$0.02753/18/20243/19/20243/22/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANVSAnnovis BioN/A2.392.39PDPInvesco Dorsey Wright Momentum ETFN/AN/AN/ARENECartesian Growth Co. IIN/A0.220.22SBMProShares Short Basic MaterialsN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipANVSAnnovis Bio15.83%PDPInvesco Dorsey Wright Momentum ETFN/ARENECartesian Growth Co. II58.96%SBMProShares Short Basic MaterialsN/AInsider OwnershipCompanyInsider OwnershipANVSAnnovis Bio38.30%PDPInvesco Dorsey Wright Momentum ETFN/ARENECartesian Growth Co. II20.00%SBMProShares Short Basic MaterialsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableANVSAnnovis Bio611.01 million6.79 millionOptionablePDPInvesco Dorsey Wright Momentum ETFN/A12.89 millionN/AOptionableRENECartesian Growth Co. IIN/A21.62 million17.30 millionNot OptionableSBMProShares Short Basic MaterialsN/A40,000N/ANot OptionablePDP, DEST, RENE, ANVS, and SBM HeadlinesSourceHeadlineFTSEAthex Basic Materials (FTATBM)investing.com - April 17 at 1:11 PMFundamentals of Materials for Energy and Environmental Sustainabilitycambridge.org - March 24 at 5:46 PMSh4b set aside for CBC classrooms missingstandardmedia.co.ke - February 25 at 10:22 PMTTT ProShares UltraPro Short 20+ Year Treasury ETFseekingalpha.com - December 24 at 6:36 PMProShares Short Basic Materials (SBM)finance.yahoo.com - November 23 at 7:46 AMAll Indicesthestreet.com - September 18 at 9:22 PMProShares Short Financials (SEF)investing.com - August 24 at 3:19 PMProShares Short Basic Materials Newsthestreet.com - August 23 at 11:58 PMVolatile Market Conditions Could Drive Investors to Tradeinvestopedia.com - July 23 at 10:52 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeCharles Schwab Fortifies its Uptrend on EPS Beat April 23, 2024 10:15 AMView Charles Schwab Fortifies its Uptrend on EPS Beat Biotech Sector Nears Breakout: Will it Outperform in Q2?April 3, 2024 6:10 AMView Biotech Sector Nears Breakout: Will it Outperform in Q2?All Headlines Company DescriptionsAnnovis BioNYSE:ANVSAnnovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.Invesco Dorsey Wright Momentum ETFNASDAQ:PDPPowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Cartesian Growth Co. IINASDAQ:RENECartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.ProShares Short Basic MaterialsNYSEARCA:SBMProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
